Wolff M R, Buck S H, Stoker S W, Greaser M L, Mentzer R M
Department of Medicine, University of Wisconsin, Madison 53792, USA.
J Clin Invest. 1996 Jul 1;98(1):167-76. doi: 10.1172/JCI118762.
To examine the role of alterations in myofibrillar function in human dilated cardiomyopathies, we determined isometric tension-calcium relations in permeabilized myocytesized myofibrillar preparations (n = 16) obtained from left ventricular biopsies from nine patients with dilated cardiomyopathy (DCM) during cardiac transplantation or left ventricular assist device implantation. Similar preparations (n = 10) were obtained from six normal hearts used for cardiac transplantation. Passive and maximal Ca2+-activated tensions were similar for the two groups. However, the calcium sensitivity of isometric tension was increased in DCM compared to nonfailing preparations ([Ca2+]50=2.46+/-0.49 microM vs 3.24+/-0.51 microM, P < 0.001). In vitro treatment with the catalytic subunit of protein kinase A (PKA) decreased calcium sensitivity of tension to a greater degree in failing than in normal preparations. Further, isometric tension-calcium relations in failing and normal myofibrillar preparations were similar after PKA treatment. These findings suggest that the increased calcium sensitivity of isometric tension in DCM may be due at least in part to a reduction of the beta-adrenergically mediated (PKA-dependent) phosphorylation of myofibrillar regulatory proteins such as troponin I and/or C-protein.
为研究肌原纤维功能改变在人类扩张型心肌病中的作用,我们测定了在心脏移植或植入左心室辅助装置期间,从9例扩张型心肌病(DCM)患者的左心室活检获取的通透化肌细胞大小的肌原纤维制剂(n = 16)中的等长张力 - 钙关系。从用于心脏移植的6个正常心脏获取了类似的制剂(n = 10)。两组的被动和最大钙激活张力相似。然而,与非衰竭制剂相比,DCM中等长张力的钙敏感性增加([Ca2 + ]50 = 2.46±0.49 microM对3.24±0.51 microM,P <0.001)。用蛋白激酶A(PKA)的催化亚基进行体外处理,与正常制剂相比,衰竭制剂中张力的钙敏感性降低程度更大。此外,PKA处理后,衰竭和正常肌原纤维制剂中的等长张力 - 钙关系相似。这些发现表明,DCM中等长张力的钙敏感性增加可能至少部分归因于肌原纤维调节蛋白如肌钙蛋白I和/或C蛋白的β-肾上腺素能介导(PKA依赖性)磷酸化的减少。